Condensed Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 23,272	$ 14,110
General and administrative	13,629	11,094
Total operating expenses	36,901	25,204
Loss from operations	(36,901)	(25,204)
Other income (expense):
Other income		503
Interest income (expense), net	5	(10)
Total other income	5	493
Net loss	(36,896)	(24,711)
Deemed dividend arising from warrant modification	(622)
Net loss attributable to common stockholders	$ (37,518)	$ (24,711)
Per share information:
Net loss per common share, Basic	$ (3.09)	$ (2.14)
Net loss per common share, Diluted	$ (3.09)	$ (2.14)
Weighted-average common shares outstanding, Basic	12,126,573	11,538,668
Weighted-average common shares outstanding, Diluted	12,126,573	11,538,668